Meeting NewsVideo

VIDEO: Antithrombotic therapy strategies in diabetes 'rapidly evolving'

PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Heart and Vascular Center and professor of medicine at Harvard Medical School, provides insights on the use of antithrombotic therapy in patients with diabetes.

Antithrombotic therapy in patients with diabetes has been “rapidly evolving” over the past few years, Bhatt, Cardiology Today’s Intervention Chief Medical Editor and Cardiology Today Editorial Board Member, said here.

Bhatt highlights updates in use of aspirin, duration of dual antiplatelet therapy and new data that show beneficial effects of aspirin plus a low-dose novel oral anticoagulant in patients with diabetes.

Watch the video for more.

PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Heart and Vascular Center and professor of medicine at Harvard Medical School, provides insights on the use of antithrombotic therapy in patients with diabetes.

Antithrombotic therapy in patients with diabetes has been “rapidly evolving” over the past few years, Bhatt, Cardiology Today’s Intervention Chief Medical Editor and Cardiology Today Editorial Board Member, said here.

Bhatt highlights updates in use of aspirin, duration of dual antiplatelet therapy and new data that show beneficial effects of aspirin plus a low-dose novel oral anticoagulant in patients with diabetes.

Watch the video for more.

    See more from Heart in Diabetes